ArticleHaematologica2016

Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy.

Angelika Holler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.